Helicos' Q1 Revenues Drop Around 50 Percent as Firm Repositions

The firm reported that it had not received any revenues in the quarter tied to system sales. It had announced separately yesterday that it will reposition its focus on the molecular diagnostics industry.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories